Sandoz Group AG (XSWX:SDZ) Cash Flow from Operations: CHF1,279 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:SDZ Sandoz Group AG XSWX:SDZ
11 GF Score
Price CHF67.36
! 3 Warning Signs
View Full Analysis

What is Sandoz Group AG Cash Flow from Operations?

Sandoz Group AG XSWX:SDZ -0.15% 11 Cash Flow from Operations is CHF1,279 Mil as of Dec. 2025. GuruFocus rates XSWX:SDZ with a GF Score™ of 11/100. The stock has 3 warning signs investors should review.

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the six months ended in Dec. 2025, Sandoz Group AG's Net Income From Continuing Operations was CHF428 Mil. Its Depreciation, Depletion and Amortization was CHF224 Mil. Its Change In Working Capital was CHF531 Mil. Its cash flow from deferred tax was CHF132 Mil. Its Cash from Discontinued Operating Activities was CHF0 Mil. Its Asset Impairment Charge was CHF0 Mil. Its Stock Based Compensation was CHF42 Mil. And its Cash Flow from Others was CHF-504 Mil. In all, Sandoz Group AG's Cash Flow from Operations for the six months ended in Dec. 2025 was CHF853 Mil.


Sandoz Group AG  (XSWX:SDZ) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Sandoz Group AG's net income from continuing operations for the six months ended in Dec. 2025 was CHF428 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

Sandoz Group AG's depreciation, depletion and amortization for the six months ended in Dec. 2025 was CHF224 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Sandoz Group AG's change in working capital for the six months ended in Dec. 2025 was CHF531 Mil. It means Sandoz Group AG's working capital increased by CHF531 Mil from Jun. 2025 to Dec. 2025 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Sandoz Group AG's cash flow from deferred tax for the six months ended in Dec. 2025 was CHF132 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

Sandoz Group AG's cash from discontinued operating Activities for the six months ended in Dec. 2025 was CHF0 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Sandoz Group AG's asset impairment charge for the six months ended in Dec. 2025 was CHF0 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Sandoz Group AG's stock based compensation for the six months ended in Dec. 2025 was CHF42 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Sandoz Group AG's cash flow from others for the six months ended in Dec. 2025 was CHF-504 Mil.


Sandoz Group AG Cash Flow from Operations Related Terms


Sandoz Group AG Cash Flow from Operations Historical Data

* Premium members only.

The historical data trend for Sandoz Group AG's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG Cash Flow from Operations Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Cash Flow from Operations
1,139.35 313.06 584.89 1,270.26

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow from Operations Get a 7-Day Free Trial 239.55 204.68 380.71 425.30 853.48
XSWX:SDZ
11GF Score
Sandoz Group AG XSWX:SDZ
Cash Flow from Operations is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sandoz Group AG Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Sandoz Group AG's Cash Flow from Operations for the fiscal year that ended in Dec. 2025 is calculated as:

Sandoz Group AG's Cash Flow from Operations for the quarter that ended in Dec. 2025 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF1,279 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Operations of CHF1,279 Mil mean?
Sandoz Group AG (XSWX:SDZ) has a Cash Flow from Operations of CHF1,279 Mil as of Dec. 2025. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for Sandoz Group AG and its competitors.
Is Sandoz Group AG's Cash Flow from Operations too high?
Sandoz Group AG's current Cash Flow from Operations is CHF1,279 Mil. Overall, Sandoz Group AG has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Sandoz Group AG's Cash Flow from Operations compare to ZTS and UTHR?
Sandoz Group AG's Cash Flow from Operations of CHF1,279 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Operations for a Drug Manufacturers company?
A good Cash Flow from Operations depends on the Drug Manufacturers industry context. However, Cash Flow from Operations should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Operations mean?
A high Cash Flow from Operations can signal that a stock is expensive relative to its fundamentals. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for Sandoz Group AG and its competitors. Sandoz Group AG's current Cash Flow from Operations is CHF1,279 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sandoz Group AG stock overvalued right now?
Sandoz Group AG (XSWX:SDZ) has a current Cash Flow from Operations of CHF1,279 Mil. The current Cash Flow from Operations is CHF1,279 Mil. Sandoz Group AG's overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Operations calculated?
Cash Flow from Operations is calculated from a company's financial statements. For Sandoz Group AG (XSWX:SDZ), the current Cash Flow from Operations is CHF1,279 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sandoz Group AG Business Description

Address Centralbahnstrasse 4, Basel, CHE, 4051
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
11GF Score

Get the complete analysis for XSWX:SDZ

Cash Flow from Operations is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF67.36
Price